Stephen O'Flanagan

9PUBLICATIONS
64CO-AUTHORS
Tumour immunologyHaematological tumoursInnate immunityMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 09, 2026
Intratumoral T cell activation kills tumors regardless of T cell specificity.

|Aug 26, 2025
Chronic NK cell activation results in a dysfunctional, tissue resident-like state mediated by KLF2 deficiency.

Jacob A Myers, Rih-Sheng Huang, Shee Kwan Phung

|Apr 15, 2024
Cutting Edge: First Lung Infection Permanently Enlarges Lymph Nodes and Enhances New T Cell Responses.

J Michael Stolley, Milcah C Scott, Stephen D O'Flanagan

|Jun 02, 2023
Chronic antigen in solid tumors drives a distinct program of T cell residence.

Noah V Gavil, Milcah C Scott, Eyob Weyu

|Dec 02, 2022
Route of self-amplifying mRNA vaccination modulates the establishment of pulmonary resident memory CD8 and CD4 T cells.

Marco Künzli, Stephen D O'Flanagan, Madeleine LaRue

|May 19, 2022
P2RX7 Enhances Tumor Control by CD8+ T Cells in Adoptive Cell Therapy.

Kelsey M Wanhainen, Changwei Peng, Maggie H Zhou

Pageof 2

Frequent Collaborators

4 joint publications

Sathi Wijeyesinghe

4 joint publications

J Michael Stolley

4 joint publications

David Masopust

4 joint publications

Eyob Weyu